Meetings International proudly announces the 2nd International Conference on Pharmaceutics & Novel Drug Delivery Systems scheduled during December 03-04, 2018 at Sydeny, Australia. With a theme of "Advances and Innovations in Pharmaceutics & Drug Delivery Technology ".
The popularity of Formulation and Drug Delivery has increased significantly in recent years. The Drug Delivery Technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Drug delivery technology market offers a promising approach for the delivery of various kinds of drugs that have different molecular formulation. Drug delivery technology is aimed at maximizing the drug delivery at the targeted site so as to increase the efficiency of drug and proposing improved patient compliance.
Pharmaceutics Meeting 2018 will bring together key decision makers and innovators within this rapidly growing field. This intensive 2-Day program will examine various formulation and drug delivery strategies. The event will cover Pre-Formulation & Formulation Aspects, Pharmacokinetics and Pharmacodynamics, Drug Targeting, Drug Delivery Routes, Novel Drug Delivery Systems, Nanotechnology in Drug Delivery, Nano Drug Delivery Systems, Pharmaceutical Nanotechnology, Smart Drug Delivery Systems, Vaccine Drug Delivery Systems, Peptides and Protein Drug Delivery, Theranostics and Molecular Diagnosis, Biomaterials, Nanomedicine Forum, Polymers in Drug delivery and Tissue engineering and Regenerative Medicine
Additionally, the event will examine novel strategies for improving Vaccine Drug Delivery Systems, including stability and half-life will also be discussed along with novel routes of administration. Case studies will be presented that illustrate the progress made in developing efficacious drug therapeutics, while leaders in the field point the way to the future for these promising drugs.
Join the industry’s leading drug development executives from numerous leading organizations to discuss and hear unique take-home examples, case studies and multiple drug development and delivery strategies to assist in reducing time-to-market on future drug products.
Attend to gain an unmatched experience in the Drug Delivery field.
Pharmaceutics Meeting 2018 will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other novel development strategies from some of our workshops and symposiums. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel drug development and commercialization strategies, which could speed up time to market and save your organization millions. We hope you will join us in Osaka, Japan this July to enhance your drug delivery capabilities, and increase time to market on therapeutics.
Pharmaceutics is the applied science of dosage form design. In that Preformulation study is a stage of development process in which the physicochemical properties of drug substance are characterized. These Preformulation studies are an important component of drug development wherein it helps development of formulations, for various stages of clinical trials. It provides the scientific basis for formulation development. It assists scientists during screening process of lead candidates based on their physicochemical and biopharmaceutical properties. This data is useful for selection of new chemical entities (NCEs) for preclinical studies which is a major section of drug development.
Pharmacokinetics is the study of how is the drug absorbed, distributed, metabolized and excreted in the body. Population pharmacokinetics is the study of pharmacokinetic differences of a drug in different population groups. Clinical pharmacokinetics is defined as the applications of pharmacokinetic principles in the safe and effective management of individual patient. Toxic kinetics is defined as the applications of pharmacokinetic principles to the design, conduct and interpretation of drug safety evaluation studies.
Pharmacodynamics is the study of the impact of drugs on the body; the primary focus is the mechanisms by which the drugs exert their therapeutic & adverse effects. As the dose changes the type and degree of the response changes. Bioavailability is the proportion of the administered dose that reaches the systemic circulation.
Track 3: Drug Targeting
The new drug target discovery and exploitation is a key for both the pharmaceutical industry and academic research. To ensure an insight into trends in the exploitation of new drug targets analysed the drugs that were approved by the US Food and Drug Administration.The main drawbacks in systemic drug administration are Lack of drug affinity towards the pathological site and nonspecific toxicity and other adverse effects so drug targeting may resolve some these problems. Drug target can serve both as a therapeutic approach and research tool in normal physiology and under patho-physiolocal conditions. Computer Aided Drug Design is the tool used to predict whether the small molecule will bind the target site and how strongly bind to the binding site. Molecular mechanics and molecular dynamic studies also used to estimate the interaction strength between the drug molecule and the binding site.
Track 4: Drug Delivery Routes
Route of administration is the way by which the drug molecule entering into the body. Route of administrations are basically classified based the application location of the drug molecule.The differences in routes of administration of various drugs, and the regional differences in routes of use, have implications for the provision of preventive and treatment services. Needle exchange schemes and interventions targeted at drug overdose may be more suitable in areas of high injecting prevalence. Further research into regional differences in routes of drug use should be conducted with non-clinical samples.
Track 5: Novel drug Delivery Systems
Drug delivery is the method or process of administering pharmaceutical compound to achieve a therapeutic effect in humans or animals. Many medications such as proteins and peptides, antibody, vaccine and gene based drugs, may not be administered by these routes because they might be susceptible to enzymatic degradation due to molecular size etc. The conventional dosage forms provide drug release immediately and cause fluctuation of drug level in blood depending upon dosage form. Therefore to maintain the drug concentration within therapeutically effective range needs novel drug delivery system. NDDS is advanced drug delivery system which improves drug potency, control drug release to give a sustained therapeutic effect, provide greater safety finally it is to target a drug specifically to a desired tissue. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Modes of NDDS are; Targeted Drug Delivery System, Controlled Drug Delivery System, Modulated Drug Delivery System
Track 6: Nano Drug Delivery Systems
A nano drug delivery system contains a core, a particle or emulsion prepared by chemical methods act as a carrier. Therapeutic molecules and ligand are added to the core for targeting specific site. Nano drugs are distributed throughout the body via nano sized capsules. The major targets in the development of nano drugs are specific drug targeting and delivery, more safety and biocompatibility, rapid development of new medicine with a wide safety margin; and improved pharmacokinetic properties, Theoretically, nano drugs can easily pass through the fine capillary blood vessels and the lymphatic endothelium, higher binding capability and accumulation at target sites, In particular, nanotechnologies have been used to develop site-specific drug targeting, for the treatment of brain diseases and cancer.
Track 7: Pharmaceutical Nanotechnology
Pharmaceutical Nanotechnology has wide applications like nanoemulsions enhancing the absorption of a drug in particular site, increasing the microbial stability of product, to develop the molecules as tracer maker in identifying the toxic materials. A large number of nanosystems have been found in pharmacy field today are liposomes, metallic nanoparticles, polymeric nanoparticles, carbon nanotubes, quantum dots, nanofibres etc. It provides opportunities to improve materials, medical devices and help to develop new technologies where existing and more conventional technologies may be reaching their limits.
Track 8: Smart Drug Delivery Systems
Smart drug delivery system (SDDS) is the multi targeted, pH responsive, Stimuli sensitive delivery systems in which delivering the medication to a patient in a manner that increases the concentration of the medication in some parts of the body. Smart drug delivery systems are the future and developing effective delivery systems. Nanotechnology based smart drug delivery systems are proved efficient in diagnosis and treatment of various diseases.
Track 9: Biomaterials
A biomaterial is any substance other than drug or combination of substances, synthetic or natural in origin. It can be used for any period of time or as a part of a system which treat diagnosis or replace any part of the body. It is used to prepare biomedical device or bio implant that is used to treat, replace or augment any tissue or organ in the body. Biomaterials are also used every day in dental applications, surgery, and drug delivery. A biomaterial is also an autograft, allograft used as a transplant material. ECM and ECM-like materials, or ECM-synthetic polymer hybrids, used as biomaterials in the field of regenerative medicine,
Track 10: Vaccine Drug Delivery Systems
Vaccine is a material that can produce an immunologically mediated resistance to a disease. Vaccines are prepared by killed or attenuated microorganisms. Vaccine drug delivery systems are getting popularity due to benefits they offer. Needle free technology, edible vaccines used for oral delivery of vaccines. Reason behind development of vaccines as controlled drug delivery systems are ; 1) Immunization failure with conventional immunization regimen, 2) Allow for the incorporation of doses of antigens so that booster doses are no longer necessary as antigens are released slowly in a controlled manner 3) Control the spatial and temporal presentation of antigens to the immune system there by promoting their targeting straight to the immune cells.
Track 11: Peptides and Protein Prug Delivery
Proteins and peptides are the most abundant components of biological systems. Peptides and proteins are attracting increasing in attention as therapeutics. Transdermal peptide therapeutics avoids the problems with GI tract. The clinical peptide therapeutic pipeline composed of 128 peptide therapeutics. The recent advances in the peptide and protein drug delivery systems are PEGylation and Depo-foam technology. Cell-penetrating peptides (CPPs) act as cargo carriers and constitute a current hotspot in medical research. CPPs to transport hydrophilic macromolecules into cells, thus, assist to execute biological functions. CPPs do not destroy the integrity of the cell membranes, and are considered more efficient and safe and providing new avenues for research and applications in life sciences.
Track 12: Theranostics and Molecular Diagnosis
Theranostics is defined as the combination of diagnostics and therapeutics. In this technology radio-nuclide labeled agents are used to diagnose the disease and subsequently use identical agents to treat the disease itself. Now-a-days this technology used in the cancer treatment as cancer theranostics. Theranostics nanomedicine may be defined as nanomedicine that combines diagnostics with therapeutics. Nanotheranostics is to apply and further develop nanomedicine strategies for advanced theranostics. It can also produce stimuli-responsive release, synergetic and combinatory therapy, siRNA co-delivery, multimodality therapies, oral delivery, delivery across the blood-brain barrier.
Track 13: Nanomedicine Forum
Nanomedicine is a branch of medicine that applies the tools of nanotechnology to the prevention, diagnosis and treatment of disease. Nanomedicine includes the utilization of nanoscale materials, for example, biocompatible nanoparticles and nanorobots, for delivery, detecting or activation purposes in\a living organisms. Nanomedicine utilizes the enhanced and novel physical, chemical and biological properties of materials at the nanometer scale. Today, nanomedicines are utilized globally to enhance the treatments and lives of patients experiencing a scope of diseases including ovarian and breast tumours, kidney disorders, contagious infections, menopausal indications, different sclerosis, asthma and emphysema.
Track 14: Polymers in Drug delivery
Biopolymers are polymers synthesized by living organisms. Biopolymers are polynucleotides, polypeptides or polysaccharides. These carries with it long chains manufactured from continuance, covalently warranted units, like nucleotides, amino acids or monosaccharides.
Regenerative Medicine is another branch of medicine that used to change the course of chronic diseases. This is rapidly getting to be noticeably one of the most encouraging treatment alternatives for patients experiencing tissue failures. Tissue Engineering and Regenerative Medicine is appealing to researchers, doctors, and laypeople alike: to regenerate tissue or organ defects. Tissue engineering consolidates cells, building, and materials techniques with appropriate biochemical and physiochemical variables to enhance or supplant biologic functions.
Pharmaceutics Meeting 2017 Report
Meetings International successfully anchored its leading "Global Experts Meeting on Pharmaceutics & Drug Delivery Systems (Pharmaceutics Meeting 2017) scheduled during October 12 to 13, 2017 at Osaka, Japan.
Pharmaceutic Meeting 2017 is distinguished with the attendance of Editorial Board Members of supported Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference rewarding and fecund.
Our Global Experts Meeting on Pharmaceutics & Drug Delivery Systems scheduled during October 12 to 13, 2017 at Osaka, Japan. With a theme of "Novel approaches, trends and challenges in Drug Delivery Systems". which has encrusted the below
• Formulation Aspects
• Pharmacokinetics and Pharmacodynamics
• Drug Targeting
• Drug Delivery Routes
• Nano Drug Delivery Systems
• Nanotechnology in Drug Delivery
• Pharmaceutical Nanotechnology
• Smart Drug Delivery Systems
• Applications of Biomaterials
• Vaccine Drug Delivery Systems
• Peptides and Protein Drug Delivery
The conference was initiated with the Honorable presence of the Keynote forum. The list includes:
Romana Zelko, Semmelweis University, Hungary
Meetings International wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Honourable guests, Valuable speakers, Poster presenters, students, delegates and special thanks to the Media Partners (Bentham Science, Depharm, JSB Conferences, JSB Market Research, SciDoc Publishers,Technology Networking, Pharma Circle, Pharma Focus Asia, and Pharma Voice.Com) for their promotion to make this event a huge success.
With the enormous feedback from the participants and supporters of Global Experts Meeting on Pharmaceutics & Drug Delivery Systems, Meetings International is glad to announce “2nd Global Experts Meeting on Pharmaceutics & Drug Delivery Systems” (Pharmaceutics Meeting 2018) scheduled during August 15-16, 2018 at Tokyo, Japan
For more details about Pharmaceutics Meeting 2018, please Visit: http://www.meetingsint.com/pharma-conferences/pharmaceutics